Skip to main content

Advertisement

SpringerLink
Log in

A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Al Hothali GI (2013) Review of the treatment of mycosis fungoides and Sézary syndrome: a stage-based approach. Int J Health Sci (Qassim) 7(2):220–239

    Article  Google Scholar 

  2. Sirois DA, Miller AS, Harwick RD, Vonderheid EC (1993) Oral manifestations of cutaneous T-cell lymphoma. A report of eight cases. Oral Surg Oral Med Oral Pathol 75(6):700–705

    Article  PubMed  CAS  Google Scholar 

  3. Schmitz N, Trümper L, Ziepert M, Nickelsen M, Ho AD, Metzner B, Peter N, Loeffler M, Rosenwald A, Pfreundschuh M (2010) Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood 116(18):3418–3425

    Article  PubMed  CAS  Google Scholar 

  4. Jidar K, Ingen-Housz-Oro S, Beylot-Barry M et al (2009) Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases. Br J Dermatol 161:660–663

    Article  PubMed  CAS  Google Scholar 

  5. Gomez-De La Fuente E, Rodriguez-Peralto JL, Ortiz PJ, Barrientos N, Vanaclocha F, Iglesias L (2000) Oral involvement in mycosis fungoides: report of two cases and a literature review. Acta Derm Venereol 80:299–301

    Article  Google Scholar 

  6. Kwong YL (2014) Alemtuzumab induced complete remission of romidepsin-refractory large cell transformation of mycosis fungoides. Ann Haematol (Germany) 93(4):713–714

    Article  Google Scholar 

  7. Lundin J, Hagberg H, Repp R et al (2003) Phase 2 study of alemtuzumab (anti-CD52 monoclonalantibody) in patients with advanced mycosis fungoides/Sezary syndrome. Blood 101:4267–4272

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Istituto di Ematologia, Dipartimento di Biomedicina e Prevenzione, Università Tor Vergata, Viale Oxford 81, 00133, Rome, Italy

    M. Postorino, L. Pupo, I. Provenzano, M. I. Del Principe, F. Buccisano, L. Franceschini, M. Rizzo, D. Nasso, F. Meconi, I. Onnis, S. Vaccarini, A. Zizzari, M. Cantonetti & S. Amadori

  2. Anatomia Patologica, Università Tor Vergata, Viale Oxford 81, 00133, Rome, Italy

    L. Anemona

  3. Dipartimento di Otorinolaringoiatria, Università Tor Vergata, Viale Oxford 81, 00133, Rome, Italy

    S. Mauramati & E. Bruno

Authors
  1. M. Postorino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Pupo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Provenzano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. I. Del Principe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Buccisano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Franceschini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Rizzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D. Nasso
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. F. Meconi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. I. Onnis
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. S. Vaccarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A. Zizzari
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. L. Anemona
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. S. Mauramati
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. E. Bruno
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. M. Cantonetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. S. Amadori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Postorino.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Postorino, M., Pupo, L., Provenzano, I. et al. A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy. Ann Hematol 95, 153–154 (2016). https://doi.org/10.1007/s00277-015-2503-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2503-z

Keywords

Search

Navigation